Discrepancy between Mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation. - Wikidata - wikimedia - TriplyDB

Discrepancy between Mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation.

Discrepancy between Mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation.

http://www.wikidata.org/entity/Q42413222

about

A three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and T-SPOT.TB in children Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons?Incidence and correlates of tuberculosis IGRA conversion among HIV-infected postpartum women New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response.Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country.Heparin-binding-hemagglutinin-induced IFN-gamma release as a diagnostic tool for latent tuberculosis.Screening for tuberculosis infection among newly arrived asylum seekers: comparison of QuantiFERONTB Gold with tuberculin skin test School based screening for tuberculosis infection in Norway: comparison of positive tuberculin skin test with interferon-gamma release assay.In vivo and in vitro effects of antituberculosis treatment on mycobacterial interferon-gamma T cell response.Evaluation of interferon-gamma release assays in the diagnosis of recent tuberculosis infection in health care workers IFNgamma response to Mycobacterium tuberculosis, risk of infection and disease in household contacts of tuberculosis patients in Colombia.Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity Kinetics of a tuberculosis-specific gamma interferon release assay in military personnel with a positive tuberculin skin test.Prospective monitoring reveals dynamic levels of T cell immunity to Mycobacterium tuberculosis in HIV infected individuals Risk stratification of latent tuberculosis defined by combined interferon gamma release assays.Comparison of whole blood and PBMC assays for T-cell functional analysis.A comparison of an interferon-gamma release assay and tuberculin skin test in refractory inflammatory disease patients screened for latent tuberculosis prior to the initiation of a first tumor necrosis factor α inhibitor Broad adaptive immune responses to M. tuberculosis antigens precede TST conversion in tuberculosis exposed household contacts in a TB-endemic setting.Heparin-binding haemagglutinin, a new tool for the detection of latent Mycobacterium tuberculosis infection in hemodialysis patients Impairment of IFN-gamma response to synthetic peptides of Mycobacterium tuberculosis in a 7-day whole blood assay Discordance among commercially available diagnostics for latent tuberculosis infection.Close contact interferon-gamma response to the new PstS1(285-374):CPF10: a preliminary 1-year follow-up study.Reduced frequency of memory T cells and increased Th17 responses in patients with active tuberculosis Use of whole-blood samples in in-house bulk and single-cell antigen-specific gamma interferon assays for surveillance of Mycobacterium tuberculosis infections.Peripheral blood gamma interferon release assays predict lung responses and Mycobacterium tuberculosis disease outcome in mice Discordant QuantiFERON-TB Gold test results among US healthcare workers with increased risk of latent tuberculosis infection: a problem or solution?Added Value of Long-Term Cytokine Release Assays to Detect Mycobacterium tuberculosis Infection in HIV-Infected Subjects in Uganda.Identification of T-cell antigens specific for latent mycobacterium tuberculosis infection.Multifunctional T Cell Response to DosR and Rpf Antigens Is Associated with Protection in Long-Term Mycobacterium tuberculosis-Infected Individuals in Colombia Effect of prolonged incubation time on results of the QuantiFERON TB gold in-tube assay for diagnosis of latent tuberculosis infection.Long-incubation-time gamma interferon release assays in response to purified protein derivative, ESAT-6, and/or CFP-10 for the diagnosis of Mycobacterium tuberculosis infection in children.Key role of effector memory CD4+ T lymphocytes in a short-incubation heparin-binding hemagglutinin gamma interferon release assay for the detection of latent tuberculosis.Evaluation of gamma interferon immune response elicited by the newly constructed PstS-1(285-374):CFP10 fusion protein to detect Mycobacterium tuberculosis infection.Biomarkers of latent TB infection.Interferon gamma release assays for diagnosing active and latent tuberculosis.Enhancement of human antigen-specific memory T-cell responses by interleukin-7 may improve accuracy in diagnosing tuberculosis.Mycobacterial antigen-induced T helper type 1 (Th1) and Th2 reactivity of peripheral blood mononuclear cells from diabetic and non-diabetic tuberculosis patients and Mycobacterium bovis bacilli Calmette-Guérin (BCG)-vaccinated healthy subjects.Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection.Predicting tuberculosis: does the IGRA tell the tale?Immune-mediated inflammatory diseases differently affect IGRAs' accuracy for latent tuberculosis infection diagnosis in clinical practice.

P2860

Q21562599-58A73784-CE5D-41B7-8ACC-880F46061793 Q28749413-CCCE95BB-B620-410F-A98D-C4EB1780C61C Q29247882-F49A010B-16F2-4711-A6BC-2609EC11EEDD Q30907264-D89EED8A-EE8B-4C19-9069-13C085997DB3 Q30979334-37F94EC4-F6DC-46DC-9066-3278962317AF Q33301317-05DA6704-7A21-49D5-8694-7E1190638CCA Q33334644-C3F9E6CD-7F7C-45E4-AEAA-CAD71774E769 Q33377580-25D648A6-A113-4C6E-8599-04472E1ADE0A Q33429956-FEFF8DEA-942E-44AD-9481-C84F2277A71A Q33496134-F6E7BC2F-CE43-4365-9CB8-F2314F99EFD4 Q33518556-42BB5B59-4D5E-4B3A-A083-74CA2F3829BB Q33535876-208BF216-9B01-4489-977D-41C541D44B42 Q33909191-45D4D80E-5CC7-4F6B-906A-045788A8BFE7 Q34299551-0381DC53-8F50-4783-B2A7-8479A1259B72 Q34389498-2CD0669B-9B5E-40C4-9175-A2D9C27EA5C5 Q34636954-6856B679-770E-41DA-80C6-3017CDA7DB0D Q34709566-F5E6FBCD-61DE-4AF9-AF52-6016D9D7191F Q34790516-E0686097-1B5D-4461-A5A5-D9DB13C35CFE Q34936752-1BABA4B4-F5B2-430D-B667-7DEAAD756500 Q34949342-20728765-ED16-4470-A290-780CD7700161 Q35813659-00F1CBB7-27D2-474C-A775-459C9EF18FF4 Q36258046-BB54CBBC-006E-4216-A022-8F72FB7E6C4C Q36362277-416FDD31-5FA0-4CFE-8BC6-BC505A2B000D Q36452353-A66363DC-869B-4551-9983-8217C07BA28F Q36497632-BD3352A7-0459-4511-BBED-144DCE3CAEBA Q36626460-EF088E49-9B5D-441F-8DA2-078B2CCEC181 Q37025889-2C22E8C0-4F85-4B40-A380-CDF0FA1E838C Q37186665-D6B5B822-F38C-43BF-BEBC-328F6B5FE5DF Q37311539-90CFD114-D496-427C-B024-26D1C7122430 Q37469604-28AD959C-1315-4E43-96C6-48DD1F04C276 Q37545069-3D7F73F4-2EED-444A-A7A7-5260ACB04A49 Q37643318-BDCF5A74-36CE-491C-ABFF-CD62A0D96677 Q37712824-D74C2274-7B1E-4E65-B4CA-82B8BB1A42A9 Q37755029-DD4DC1F2-F48B-417B-A3E9-C64E71C0D81B Q38089069-AF27227E-9DA2-435A-BBD3-362FA1955333 Q41809246-FC8B0238-8830-4140-AD2D-07663BA239D9 Q44098350-6F94155C-8222-476A-B9F3-48E268C31057 Q44753732-EC795900-FF3B-450D-BD9B-019FB114B557 Q46984569-4F00F70A-AE2A-4E6E-8A61-317EDE4A8848 Q47134742-1587722F-3379-44AC-86E8-98DC12EB8225

P2860

Discrepancy between Mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation.

http://www.wikidata.org/entity/Q42413222

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Discrepancy between Mycobacter ...... prolonged in vitro incubation.

@en

Discrepancy between Mycobacter ...... prolonged in vitro incubation.

@nl

type

label

Discrepancy between Mycobacter ...... prolonged in vitro incubation.

@en

Discrepancy between Mycobacter ...... prolonged in vitro incubation.

@nl

prefLabel

Discrepancy between Mycobacter ...... prolonged in vitro incubation.

@en

Discrepancy between Mycobacter ...... prolonged in vitro incubation.

@nl

P1433

Q42413222-5E503092-40F5-43F7-BBA2-508A621DB31C

P1476

Q42413222-422002D1-508E-4EE9-8ECC-1F70C4660B2E

P2093

Q42413222-01886BB3-EDF7-4C03-BCAB-7A0354CE5E38

Q42413222-3B55F4AC-DC85-4F3E-8E1B-33D1DF533797

Q42413222-434EEA19-3C06-4DF6-9D72-990566E11071

Q42413222-72B5ED29-F997-468C-85A6-34DF1133E955

Q42413222-A928BD75-2817-4F2E-8294-AF2E08C4BAC6

Q42413222-B152FC85-2906-4520-80E0-36D96CDC3FD0

P2860

Q42413222-0566454B-E347-42EC-A082-8D063BCA3BE5

Q42413222-0E4F0E08-7228-4B4D-8357-03D47A0BE83E

Q42413222-115DBDD2-5CFC-4CF6-B885-36B5D09173AA

Q42413222-11A25D1F-1D39-456A-A0C3-A4125C611D9E

Q42413222-1325AC38-9354-49EB-94D6-721B06F2A357

Q42413222-133E893D-B0F9-46E7-94DC-F3D3C594A7CA

Q42413222-27B0E4CC-83B8-4709-B340-223163E338E7

Q42413222-3A7F5E36-D169-4504-899F-92D7D4A79BD4

Q42413222-3B80B991-0107-4C18-BA2E-56FB490DCF04

Q42413222-52CF3C33-CDDF-43B1-8F8F-420FF7BC5D47

P304

Q42413222-333534E5-E629-4BA9-A2F1-8E1F28752CAA

P31

Q42413222-2558A58D-4BE0-4BF0-9AD3-D6AB0EEB29F8

P356

Q42413222-112188E4-0036-401A-9372-B8EB611760DA

P433

Q42413222-59BD30CD-95F4-445C-B3EC-A4E88FD04729

P478

Q42413222-10E22815-0C54-42C3-AFD2-BD8032CD5F07

P577

Q42413222-FD733A40-AA6D-4EB5-9903-8A0DE95353AA

P5875

Q42413222-B539B21C-E061-40BD-9AE6-B8A52D5B2440

P698

Q42413222-9C14E959-A475-4C48-A7C2-C30A5B95512B

P921

Q42413222-B0290C70-A40C-491B-A4DA-983EE20B1F3B

P932

Q42413222-231CBFFF-6737-42FE-B85B-F5DAE71B93F6

P356

P1433

Clinical and Vaccine Immunology

P1476

Discrepancy between Mycobacter ...... prolonged in vitro incubation.

@en

P2093

Corine Prins

http://www.w3.org/2001/XMLSchema#string

Eliane M S Leyten

http://www.w3.org/2001/XMLSchema#string

Frank G J Cobelens

http://www.w3.org/2001/XMLSchema#string

Jaap T van Dissel

http://www.w3.org/2001/XMLSchema#string

Sandra M Arend

http://www.w3.org/2001/XMLSchema#string

Tom H M Ottenhoff

http://www.w3.org/2001/XMLSchema#string

P2860

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

Enzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection.

Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells.

Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak.

Comparison of a new ESAT-6/CFP-10 peptide-based gamma interferon assay and a tuberculin skin test for tuberculosis screening in a moderate-risk population.

Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study.

Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons.

Persistently elevated T cell interferon-gamma responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report

Specific T-cell epitopes for immunoassay-based diagnosis of Mycobacterium tuberculosis infection.

Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review.

P304

880-885

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/CVI.00132-07

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2007-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6324016

http://www.w3.org/2001/XMLSchema#string

P698

17507543

http://www.w3.org/2001/XMLSchema#string

P921

Mycobacterium tuberculosis

P932

1951056

http://www.w3.org/2001/XMLSchema#string